Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
10/2000
10/25/2000EP0660699B1 Hair relaxer compositions
10/25/2000CN1271274A Hair conditioner and 2-in-1 conditioning shampoo
10/25/2000CN1271273A Cleaning compositions
10/25/2000CN1271271A Cleaning compositions
10/25/2000CN1271268A Fluoride dentifrices of enhanced efficacy
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1057703C Method for preparing contrast media
10/25/2000CN1057673C Tablet, capsule, or granule comprising desogestrel
10/25/2000CA2367208A1 Oxidation dyeing method using n-acetylcysteine as a reducing agent and laccase as an oxidating agent
10/24/2000US6136809 Azolo triazines and pyrimidines
10/24/2000US6136344 Oral pharmaceutical dosage form
10/19/2000WO2000061590A1 Process for preparing amine platinum complexes
10/19/2000WO2000061161A2 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation
10/19/2000WO2000061160A2 A pharmaceutical formulation useful for the treatment of hepatitis b hepatitis c and other viral infections of the liver and a pr ocess for its preparation
10/19/2000WO2000061152A1 Management of pain after joint surgery
10/19/2000WO2000061122A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions
10/19/2000WO2000061094A1 Antiperspirant compositions
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000042992A3 Compositions and methods for mucosal delivery
10/19/2000CA2815763A1 Anti-bacterial vaccine compositions
10/19/2000CA2815566A1 Pasteurellaceae bacteria comprising a mutated virulence gene and an anti-bacterial vaccine prepared therefrom
10/19/2000CA2369301A1 Management of pain after joint surgery
10/19/2000CA2334754A1 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP0750492B1 Inhalation composition containing lactose pellets
10/18/2000CN1270592A Spiroazabicyclic heterocyclic compounds
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270515A Methods and compositions for treating pulmonary disorders using optically pure(S)-salmeterol
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1270021A Anhydrous composition for bleaching keratin fibers
10/18/2000CN1270020A Aqueous composition for bleaching keratin fibers instantaneously
10/17/2000US6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
10/17/2000CA2006719C Antibacterial antiplaque oral composition
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2000EP1041990A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
10/11/2000EP1041963A1 Non-whitening underarm compositions
10/11/2000EP1041921A2 Preemptive prophylaxis of migraine device and method
10/11/2000CN1269800A Tetrahydro Gamma-carbolines
10/11/2000CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
10/10/2000US6130254 Methods for inhibiting photoaging of skin
10/10/2000US6129923 Treatment of H. pylori associated gastroduodenal disease
10/10/2000US6129918 Method and pharmaceutical composition for reducing serum homocysteine concentration
10/10/2000US6129907 Stable hydrogenated lupulone antibacterial oral compositions
10/10/2000CA2056421C Agent against autoimmune diseases
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000057866A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections
10/05/2000WO2000057865A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia
10/05/2000WO2000032228A3 Peptide-based vaccine for influenza
10/05/2000WO2000030625A3 Use of phosphonoformic acid derivatives for treating infections
10/05/2000WO2000027338A3 Fluorinated toothpaste composition comprising calcic material abrasive particles compatible with fluorine
10/05/2000CA2368597A1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000CA2366012A1 Methods of treating leukemia
10/04/2000EP1040094A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
10/04/2000EP1039882A1 Therapeutic formulation for administering tolterodine with controlled release
10/04/2000CN1268942A Sulfonamide compounds and medicinal use thereof
10/04/2000CN1268885A Oral compositions
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/03/2000US6127527 Apparatus for the therapeutic use of 213 Bi
10/03/2000US6126923 Concurrent extrusion of different colored dentifrices
09/2000
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/28/2000WO2000056360A2 Vaccine against antigens from bacteriae
09/28/2000WO2000056359A2 Vaccine against streptococcus pneumoniae
09/28/2000WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
09/28/2000WO2000056348A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/28/2000WO2000056317A1 Weight loss after pregnancy
09/28/2000WO2000056314A1 Method of treating sleep apnoea
09/28/2000WO2000056313A1 Method of controlling weight gain associated with therapeutic drugs
09/28/2000WO2000056306A1 Treatment of osteoarthritis
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000CA2367699A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000CA2367268A1 Weight loss after pregnancy
09/28/2000CA2367022A1 Method of treating sleep apnoea
09/28/2000CA2367021A1 Method of controlling weight gain associated with therapeutic drugs
09/28/2000CA2366660A1 Treatment of osteoarthritis
09/28/2000CA2366152A1 Streptococcus pneumoniae vaccine
09/28/2000CA2365296A1 Vaccine
09/27/2000EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor
09/27/2000EP1038533A1 Medicinal compositions for treating immunodeficiency diseases
09/27/2000EP1037627A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
09/27/2000EP1037594A1 Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy
09/27/2000CN1268124A Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
09/27/2000CN1268120A Novel dihydronaphthalene compound and process and producing the same
09/27/2000CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/26/2000US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
09/26/2000US6124300 Treating anxiety or depression
09/26/2000US6124289 Azolo triazines and pyrimidines
09/26/2000US6124285 Indole-2,3-dione-3-oxime derivatives
09/26/2000US6124266 Sulphoquinovosyldiacylglycerol (sqdg) useful for prophylaxis or treatment of atopic dermatitis, urticaria and psoriasis, and as an antiproliferative agent
09/26/2000US6123922 Resilient deformable microballoons for echographic imaging
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
09/21/2000WO2000054736A1 Method and system for color customizing cosmetic mass products
09/21/2000WO2000038617A3 Compositions and methods of using the same
09/21/2000WO2000016746A9 Immunogenic liposome compositions
09/21/2000WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors
09/21/2000CA2332767A1 Dhea composition and method
09/20/2000EP1036558A1 Anhydrous composition for decoloration of ceratinic fibers comprising a combination of a hydrosoluble thickening polymer and an amphiphilic nonionic polymer carrying a fatty grain
09/20/2000EP1035869A1 Chemically and thermally stable norastemizole formulations
09/20/2000EP1035858A1 Use of ginkgo biloba extracts for preparing a medicine
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 295